Cyproterone Acetate Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product Type (Cyproterone Acetate Tablets, Ethinylestradiol Cyproterone Tablets); Dosage Form (Tablet, Solution); Route Of Administration (Oral, Intramuscular)and Geography

Report Code: TIPRE00008468 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

An anti-androgen that, in the form of its acetate (cyproterone acetate), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.

MARKET DYNAMICS

Cyproterone Acetate Market is anticipated to grow during the forecast period owing to rising prevalence of prostate cancer, severe acne and hirsutism as cyproterone acetate in combination with estrogen has shown positive results for treating acne. However, side effects associated with it will impede the market growth in the review period.

MARKET SCOPE

The "Global Cyproterone Acetate Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Cyproterone Acetate Market with detailed market segmentation by product type, dosage form and route of administration. The global Cyproterone Acetate Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Cyproterone Acetate Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Cyproterone Acetate Market is segmented on the basis of product type, dosage form and route of administration. On the basis of product type the market is segmented into, cyproterone acetate tablets and ethinylestradiol cyproterone tablets. Based on dosage form, the market is segmented as tablet and solution. On the basis of route of administration, the market is segmented into oral and intramuscular.?


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Cyproterone Acetate Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cyproterone Acetate Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Cyproterone Acetate Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cyproterone Acetate Market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Cyproterone Acetate Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Cyproterone Acetate Market are anticipated to lucrative growth opportunities in the future with the rising demand for Cyproterone Acetate Market in the global market. Below mentioned is the list of few companies engaged in the Cyproterone Acetate Market.

The report also includes the profiles of key Cyproterone Acetate Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Bayer
- Aa Pharma Inc
- Sigma-Aldrich
- Altimed Pharma Inc.
- Generic Medical Partners Inc.
- Mylan Pharmaceuticals
- Novopharm Limited
- Laboratoire Riva Inc.
- TEVA Canada Limited
- Fisher Scientific UK Ltd

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cyproterone Acetate Market - By Product Type
1.3.2 Cyproterone Acetate Market - By Dosage Form
1.3.3 Cyproterone Acetate Market - By Route of Administration
1.3.4 Cyproterone Acetate Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CYPROTERONE ACETATE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CYPROTERONE ACETATE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CYPROTERONE ACETATE MARKET - GLOBAL MARKET ANALYSIS
6.1. CYPROTERONE ACETATE - GLOBAL MARKET OVERVIEW
6.2. CYPROTERONE ACETATE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CYPROTERONE ACETATE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CYPROTERONE ACETATE TABLETS
7.3.1. Overview
7.3.2. Cyproterone Acetate Tablets Market Forecast and Analysis
7.4. ETHINYLESTRADIOL CYPROTERONE TABLETS
7.4.1. Overview
7.4.2. Ethinylestradiol Cyproterone Tablets Market Forecast and Analysis
8. CYPROTERONE ACETATE MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM
8.1. OVERVIEW
8.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
8.3. TABLET
8.3.1. Overview
8.3.2. Tablet Market Forecast and Analysis
8.4. SOLUTION
8.4.1. Overview
8.4.2. Solution Market Forecast and Analysis
9. CYPROTERONE ACETATE MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INTRAMUSCULAR
9.4.1. Overview
9.4.2. Intramuscular Market Forecast and Analysis
10. CYPROTERONE ACETATE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cyproterone Acetate Market Overview
10.1.2 North America Cyproterone Acetate Market Forecasts and Analysis
10.1.3 North America Cyproterone Acetate Market Forecasts and Analysis - By Product Type
10.1.4 North America Cyproterone Acetate Market Forecasts and Analysis - By Dosage Form
10.1.5 North America Cyproterone Acetate Market Forecasts and Analysis - By Route Of Administration
10.1.6 North America Cyproterone Acetate Market Forecasts and Analysis - By Countries
10.1.6.1 United States Cyproterone Acetate Market
10.1.6.1.1 United States Cyproterone Acetate Market by Product Type
10.1.6.1.2 United States Cyproterone Acetate Market by Dosage Form
10.1.6.1.3 United States Cyproterone Acetate Market by Route Of Administration
10.1.6.2 Canada Cyproterone Acetate Market
10.1.6.2.1 Canada Cyproterone Acetate Market by Product Type
10.1.6.2.2 Canada Cyproterone Acetate Market by Dosage Form
10.1.6.2.3 Canada Cyproterone Acetate Market by Route Of Administration
10.1.6.3 Mexico Cyproterone Acetate Market
10.1.6.3.1 Mexico Cyproterone Acetate Market by Product Type
10.1.6.3.2 Mexico Cyproterone Acetate Market by Dosage Form
10.1.6.3.3 Mexico Cyproterone Acetate Market by Route Of Administration
10.2. EUROPE
10.2.1 Europe Cyproterone Acetate Market Overview
10.2.2 Europe Cyproterone Acetate Market Forecasts and Analysis
10.2.3 Europe Cyproterone Acetate Market Forecasts and Analysis - By Product Type
10.2.4 Europe Cyproterone Acetate Market Forecasts and Analysis - By Dosage Form
10.2.5 Europe Cyproterone Acetate Market Forecasts and Analysis - By Route Of Administration
10.2.6 Europe Cyproterone Acetate Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cyproterone Acetate Market
10.2.6.1.1 Germany Cyproterone Acetate Market by Product Type
10.2.6.1.2 Germany Cyproterone Acetate Market by Dosage Form
10.2.6.1.3 Germany Cyproterone Acetate Market by Route Of Administration
10.2.6.2 France Cyproterone Acetate Market
10.2.6.2.1 France Cyproterone Acetate Market by Product Type
10.2.6.2.2 France Cyproterone Acetate Market by Dosage Form
10.2.6.2.3 France Cyproterone Acetate Market by Route Of Administration
10.2.6.3 Italy Cyproterone Acetate Market
10.2.6.3.1 Italy Cyproterone Acetate Market by Product Type
10.2.6.3.2 Italy Cyproterone Acetate Market by Dosage Form
10.2.6.3.3 Italy Cyproterone Acetate Market by Route Of Administration
10.2.6.4 Spain Cyproterone Acetate Market
10.2.6.4.1 Spain Cyproterone Acetate Market by Product Type
10.2.6.4.2 Spain Cyproterone Acetate Market by Dosage Form
10.2.6.4.3 Spain Cyproterone Acetate Market by Route Of Administration
10.2.6.5 United Kingdom Cyproterone Acetate Market
10.2.6.5.1 United Kingdom Cyproterone Acetate Market by Product Type
10.2.6.5.2 United Kingdom Cyproterone Acetate Market by Dosage Form
10.2.6.5.3 United Kingdom Cyproterone Acetate Market by Route Of Administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cyproterone Acetate Market Overview
10.3.2 Asia-Pacific Cyproterone Acetate Market Forecasts and Analysis
10.3.3 Asia-Pacific Cyproterone Acetate Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Cyproterone Acetate Market Forecasts and Analysis - By Dosage Form
10.3.5 Asia-Pacific Cyproterone Acetate Market Forecasts and Analysis - By Route Of Administration
10.3.6 Asia-Pacific Cyproterone Acetate Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cyproterone Acetate Market
10.3.6.1.1 Australia Cyproterone Acetate Market by Product Type
10.3.6.1.2 Australia Cyproterone Acetate Market by Dosage Form
10.3.6.1.3 Australia Cyproterone Acetate Market by Route Of Administration
10.3.6.2 China Cyproterone Acetate Market
10.3.6.2.1 China Cyproterone Acetate Market by Product Type
10.3.6.2.2 China Cyproterone Acetate Market by Dosage Form
10.3.6.2.3 China Cyproterone Acetate Market by Route Of Administration
10.3.6.3 India Cyproterone Acetate Market
10.3.6.3.1 India Cyproterone Acetate Market by Product Type
10.3.6.3.2 India Cyproterone Acetate Market by Dosage Form
10.3.6.3.3 India Cyproterone Acetate Market by Route Of Administration
10.3.6.4 Japan Cyproterone Acetate Market
10.3.6.4.1 Japan Cyproterone Acetate Market by Product Type
10.3.6.4.2 Japan Cyproterone Acetate Market by Dosage Form
10.3.6.4.3 Japan Cyproterone Acetate Market by Route Of Administration
10.3.6.5 South Korea Cyproterone Acetate Market
10.3.6.5.1 South Korea Cyproterone Acetate Market by Product Type
10.3.6.5.2 South Korea Cyproterone Acetate Market by Dosage Form
10.3.6.5.3 South Korea Cyproterone Acetate Market by Route Of Administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cyproterone Acetate Market Overview
10.4.2 Middle East and Africa Cyproterone Acetate Market Forecasts and Analysis
10.4.3 Middle East and Africa Cyproterone Acetate Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Cyproterone Acetate Market Forecasts and Analysis - By Dosage Form
10.4.5 Middle East and Africa Cyproterone Acetate Market Forecasts and Analysis - By Route Of Administration
10.4.6 Middle East and Africa Cyproterone Acetate Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cyproterone Acetate Market
10.4.6.1.1 South Africa Cyproterone Acetate Market by Product Type
10.4.6.1.2 South Africa Cyproterone Acetate Market by Dosage Form
10.4.6.1.3 South Africa Cyproterone Acetate Market by Route Of Administration
10.4.6.2 Saudi Arabia Cyproterone Acetate Market
10.4.6.2.1 Saudi Arabia Cyproterone Acetate Market by Product Type
10.4.6.2.2 Saudi Arabia Cyproterone Acetate Market by Dosage Form
10.4.6.2.3 Saudi Arabia Cyproterone Acetate Market by Route Of Administration
10.4.6.3 U.A.E Cyproterone Acetate Market
10.4.6.3.1 U.A.E Cyproterone Acetate Market by Product Type
10.4.6.3.2 U.A.E Cyproterone Acetate Market by Dosage Form
10.4.6.3.3 U.A.E Cyproterone Acetate Market by Route Of Administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cyproterone Acetate Market Overview
10.5.2 South and Central America Cyproterone Acetate Market Forecasts and Analysis
10.5.3 South and Central America Cyproterone Acetate Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Cyproterone Acetate Market Forecasts and Analysis - By Dosage Form
10.5.5 South and Central America Cyproterone Acetate Market Forecasts and Analysis - By Route Of Administration
10.5.6 South and Central America Cyproterone Acetate Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cyproterone Acetate Market
10.5.6.1.1 Brazil Cyproterone Acetate Market by Product Type
10.5.6.1.2 Brazil Cyproterone Acetate Market by Dosage Form
10.5.6.1.3 Brazil Cyproterone Acetate Market by Route Of Administration
10.5.6.2 Argentina Cyproterone Acetate Market
10.5.6.2.1 Argentina Cyproterone Acetate Market by Product Type
10.5.6.2.2 Argentina Cyproterone Acetate Market by Dosage Form
10.5.6.2.3 Argentina Cyproterone Acetate Market by Route Of Administration
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CYPROTERONE ACETATE MARKET, KEY COMPANY PROFILES
12.1. BAYER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AA PHARMA INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SIGMA-ALDRICH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ALTIMED PHARMA INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GENERIC MEDICAL PARTNERS INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYLAN PHARMACEUTICALS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVOPHARM LIMITED
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LABORATOIRE RIVA INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEVA CANADA LIMITED
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. FISHER SCIENTIFIC UK LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer
2. Aa Pharma Inc.
3. Sigma-Aldrich
4. Altimed Pharma Inc.
5. Generic Medical Partners Inc.
6. Mylan Pharmaceuticals
7. Novopharm Limited
8. Laboratoire Riva Inc.
9. TEVA Canada Limited
10. Fisher Scientific UK Ltd

TIPRE00008468
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking